Study of Weekly LOC-paclitaxel Injection for Melanoma
Status:
Terminated
Trial end date:
2016-02-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to find the highest tolerable dose of
LOC-paclitaxel when given to patients with metastatic melanoma. The safety of this drug and
if it can control the disease is also being studied.